Purpose We sought to exploit the heterogeneity afforded by patient-derived tumor xenografts
(PDX) to first, optimize and identify robust radiomic features to predict response to therapy in …

Purpose Pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC) is
commonly accepted as the gold standard to assess outcome after NAC in breast cancer …

Simple Summary In breast cancer, the leading cancer type and the main cause of cancer
death in women, achieving pathological complete response after neoadjuvant …

Purpose The aim of this study was to prospectively evaluate 18 F-FDG PET/CT in predicting
response to neoadjuvant chemotherapy in large primary breast cancer. Methods Fifty …

Background In patients with triple-negative breast cancer (TNBC), pathology complete
response (pCR) to neoadjuvant chemotherapy (NAC) is associated with improved …

Purpose: To investigate the value of the metabolic tumor response assessed with 18F-
fluorodeoxyglucose positron emission tomography (FDG-PET), compared with …

Purpose To explore whether integrated 18 F-FDG PET/MRI can be used to predict
pathological response to neoadjuvant chemotherapy (NAC) in patients with breast cancer …

Purpose To assess the role of radiomics parameters in predicting pathological complete
response (pCR) to neoadjuvant chemotherapy (NAC) in patients with locally advanced …

Abstract Purpose 2-Deoxy-2-[F-18] fluoro-D-glucose (FDG) uptake may be a useful
surrogate marker for proliferation index, but the correlation has not always been clear-cut …

The goal of this study was to determine the best predictive factor among image-derived
parameters extracted from sequential 18F-FDG PET scans for early tumor response …